Director

Sr. VP, Gen Counsel, and Sec.

Sr. Vice Pres., CFO

President and CEO

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

Institution	Shares	Value	Change
Fenimore Asset Management	355,212	$75M	INCREASED
Boston Trust Walden	300,450	$63M	DECREASED
Swedbank AB	217,252	$46M	DECREASED
Congress Asset Management	170,967	$36M	INCREASED
Harvey Investment	115,960	$24M	INCREASED

Insider	Type	Shares	Value	Date
Mohsen Sohi (Director)	SELL	1,837	$390K	2026-07-01
Mohsen Sohi (Director)	EXERCISE	3,781	$270K	2026-07-01
John Adam Zangerle (Sr. VP, Gen Counsel, and Sec.)	SELL	1,419	$297K	2026-06-15
Karen L Burton (Sr. Vice Pres., CFO)	SELL	90	$19K	2026-06-04
Daniel A Carestio (President and CEO)	SELL	1,889	$401K	2026-06-04

Member	Type	Amount	Date
Gilbert Cisneros (Democrat)	PURCHASE	$1,001 - $15,000	2026-05-13
Gilbert Cisneros (Democrat)	PURCHASE	$1,001 - $15,000	2026-05-11
April Delaney	PURCHASE	$1,001 - $15,000	2026-04-30

STERIS plc (STE) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades